本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aurinia Pharmaceuticals Inc

16.96
+0.83005.15%
盤前17.060.1000+0.59%05:25 EDT
成交量:117.17萬
成交額:1,963.88萬
市值:22.57億
市盈率:7.36
高:16.97
開:16.16
低:16.10
收:16.13
52周最高:19.25
52周最低:10.34
股本:1.33億
流通股本:1.29億
量比:1.52
換手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):2.30
每股收益(LYR):2.07
淨資產收益率:66.12%
總資產收益率:15.49%
市淨率:3.67
市盈率(LYR):8.19

資料載入中...

2020/06/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

年度報告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/18

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership